Navigation Links
Alpharadin in Medical News

Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018

... AstraZeneca's zibotentan, Johnson & Johnson's abiraterone and Algeta's alpharadin will fuel market growth. Specifically, sales of Avastin will be driven by its use in combination with Taxotere and sales of alpharadin will be driven by its use in patients who are not suitable for treatment wi...

Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA

... biodistribution and dosimetry study (BC1-08) with alpharadin in HRPC patients with skeletal metastases will be ...nternational pivotal phase III clinical trial with alpharadin in HRPC patients during the first half of 2008." ...efore mid 2008 based on positive Phase II results. alpharadin is a novel bone-seeking therapeutic based on the a...
Alpharadin in Medical Technology

Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer

OSLO, Norway, January 14 /PRNewswire-FirstCall/ -- - Results Highlight the Potential of Alpharadin to Treat Bone Metastases in Major Cancer Indications Algeta ASA (OSE: ALGETA), the cancer therapeutics company, announces that with the results of the BC1-04 study reported today i...

Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin

OSLO, August 28 /PRNewswire-FirstCall/ -- - Results Further Support the Clinical Profile of This Novel Anti-Cancer Agent Under Development to Improve the Survival of Patients With Hormone Refractory Prostate Cancer (HRPC) Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company,...

Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO

OSLO, Norway, 30 May 2007 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that Professor Øyvind Bruland, of the Norwegian Radium Hospital, Oslo and founder of Algeta, will present a Poster and Discussion entitled, "Radium-223 in the treatment of metastatic h...

Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood

...ellent Phase II clinical data for our lead product alpharadin (radium-223) in prostate cancer, which was publish...rostate cancer based on positive Phase II results. alpharadin is a novel bone-seeking therapeutic based on the a...o Stock Exchange in March 2007 (Ticker: ALGETA). alpharadin and Algeta are trademarks of Algeta ASA. Forward...
Alpharadin in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...udies II-53 Debiopharm Unveils Results of Phase III Study of Trelstar in Prostate Cancer Treatment II-53 Algeta to Start Clinical Study of alpharadin in HRPC II-53 Ferring Receives FDA Approval for Degarelix in Prostate Cancer II-53 Isis and OncoGenex Reveals Positive results of OGX-011 ...

Algeta Appoints Andrew Kay as President and Chief Executive Officer

...ties and Aims to Accelerate Further Development of alpharadin in Advanced Prostate Cancer Algeta ASA (OS...will be of significant value to Algeta in bringing alpharadin to market." Mr. Kay said: "I am delighted ...g Algeta at this crucial point in its development. alpharadin has shown in all the clinical trials completed to ...
Other Tags
(Date:10/19/2014)... (PRWEB) October 19, 2014 According to ... (NINDS) the vast majority of adults (up to ... point in their lives, spending at least $50 billion ... pain includes; spinal instability, stenosis, spondylolisthesis, and symptomatic degenerative ... by wear and tear associated with the aging process, ...
(Date:10/18/2014)... Riverdale, NY (PRWEB) October 19, 2014 ... Center, specializing in long-term and rehabilitation care in the ... Carlos G. Beato, chief executive officer, was honored by ... with the CHA Corporate Alumni award at their 30th ... science degree in healthcare administration from New Jersey City ...
(Date:10/18/2014)... October 19, 2014 The ... that Hostgator ( http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), JustHost and ... in 2014. , “There are thousands ... but good suppliers are not too many. ... FatCow are the most outstanding suppliers when ...
(Date:10/18/2014)... October 19, 2014 Web hosting provides ... in websites in recent years, and the new demand ... web hosting companies that offer a variety of different ... USA has compared a lot of professional Windows web ... Bluehost ( http://www.bluehost.com/track/seohosts ), InMotion and Arvixe are the ...
(Date:10/18/2014)... College of Neuropsychopharmacology (ECNP) is pleased to announce that ... Dick Swaab, for his book, We are our Brains: ... ECNP Media Award recognises outstanding contributions to destigmatising disorders ... of € 5,000. , The ECNP Media Award was ... a better understanding of the complexity and impact of ...
Breaking Medicine News(10 mins):Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 2Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 3Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 4Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 5Health News:Carlos G. Beato Honored by New Jersey City University’s Council on Hispanic Affairs (CHA) 2Health News:Carlos G. Beato Honored by New Jersey City University’s Council on Hispanic Affairs (CHA) 3Health News:Top10BestSEOHosting.com: Best Reseller Hosting Companies Announced 2Health News:Best Web Hosting Companies In 2014 Released By SEO Hosting Review Site Best Cheap Hosting USA 2Health News:Dick Swaab wins the 2014 ECNP Media Award 2
(Date:10/14/2014)... JOLLA, CA – October 14, 2014 – Scientists from ... million from the National Institutes of Health (NIH) to ... prevalent virus-induced hemorrhagic fever disease in Africa. The study ... and why some patients die, while others survive the ... to understand the basic mechanism of how Lassa fever ...
(Date:10/14/2014)... an international team of researchers, led by the Chinese ... journal Nature Genetics a brief genomic history ... of the tomato plant. , The C.M. Rick Tomato ... role in this study by providing seed of both ... study, which builds on the first tomato genome sequence ...
(Date:10/14/2014)... – Over the past decades, we have seen numerous ... the needs of infants for social contact and stimulation ... thrive. , Infancy and childhood are critical ... A generation of research suggests that enriched environments, full ... cognitive function. In contrast, deprivation and stress may compromise ...
Breaking Biology News(10 mins):Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2Institutional rearing may increase risk attention-deficit disorder 2
Other Contents